Increasing evidence shows that hospital competition under fixed prices can improve quality and reduce cost. Concerns remain, however, that competition may undermine socio-economic equity in the utilisation of care. We test this hypothesis in the context of the pro-competition reforms of the English National Health Service progressively introduced from 2004 to 2006. We use a panel of 32,482 English small areas followed from 2003 to 2008 and a difference in differences approach. The effect of competition on equity is identified by the interaction between market structure, small area income deprivation and year. We find a negative association between market competition and elective admissions in deprived areas. The effect of pro-competition reform was to reduce this negative association slightly, suggesting that competition did not undermine equity.
Introduction
There is a substantial body of economic theory and evidence about the effects of competition on the cost and quality of hospital care (Gaynor, 2006) . It is known, for instance, that competition can improve quality (Kessler and McClellan, 2000) though not if buyers have poor information about quality (Propper et al., 2008) . Less is known, however, about the effects of competition on socio-economic inequality in hospital care (Cookson et al., 2010) .
We aim to provide some evidence in the context of the pro-competition reforms of the These "Blair/Brown" reforms fostered competition in two main ways. First, on the supply side, independent sector (IS) hospitals were encouraged gradually to enter the market for NHS funded patients: we estimate that IS activity made up 0.03% of NHS non-emergency inpatient activity in 2003/4 rising to 2.17% by 2008/9. Second, on the demand side, patients were offered a choice of hospital from December 2005 and case based hospital payment was gradually phased in from 2003/4 to 2008/9 so that money would follow the patient's choice (Department of Health, 2003) . Prime Minister Blair predicted his reforms would enhance equity for poorer patients, by increasing hospital capacity and patient choice (Blair, 2003) .
By contrast, critics predicted that choice and independent sector provision would undermine socio-economic equity (Appleby et al., 2003; Barr et al., 2008; Oliver and Evans, 2005; Tudor-Hart, 2006) . Evidence on the equity effects of competition is timely, as at the time of writing the English NHS is embarking upon another controversial programme of procompetition reform under the coalition administration of Conservative Prime Minister David Cameron and Liberal Democrat Deputy Prime Minister Nick Clegg (Department of Health, 2010 , Whitehead et al. 2010 ).
In providing evidence of this kind, one key challenge lies in disentangling the effects of hospital competition on socio-economic equity from the effects of other contemporaneous changes in the health system and the wider social and economic environment. For example, the rapid growth in NHS spending and capacity during the 2000s may have tended to improve socio-economic equity in hospital care, if activity was able to grow faster in deprived areas with greater unmet need. Changes in the wider socio-economic environment may also have played a role, for example improved access to web-based information and the ageing of the consumerist "baby boomer" generation. Our research design aims to disentangle the specific effects of competition from these broader influences on socioeconomic equity in hospital care.
We identify the effect of competition on utilisation of hospital services by exploiting geographical variation in the "dose" of competition generated by the introduction of the procompetition reforms, as measured by change in market concentration. Indices of local market concentration are constructed by computing hospital level indices based on both observed and predicted patient flows, and then attributing these to small areas using distance-weighted averages. As one would expect, the pro-competition Blair/Brown reforms were accompanied by a general fall in hospital market concentration throughout the period as competition set in.
However, local market concentration changes by different amounts in different parts of the country and over different points in time. Towards the beginning of the reform period, change in local market concentration is very small and reflects variation in local demand and supply factors. As the pro-competition reforms are gradually phased in, however, fairly large and widespread falls in local market concentration are observed which are likely to reflect increases in competitive pressure. We can therefore identify the effect of competition by comparing geographical differences in the magnitude of change in market concentration before and during the introduction of pro-competition reforms using a difference in differences (DID) approach.
The second key challenge lies in measuring change in socio-economic equity in hospital care, and doing so in a way that can be linked to change in local hospital market concentration.
Conventional individual level survey data approaches are unable to include adequately large samples of individuals using hospital care each year in all local hospital markets in England.
We therefore use administrative data on all individuals aged 18 and over who used hospital care in the English NHS from 2003 to 2008, comprising a total of 37.7 million elective inpatient hospital admissions. Unfortunately, this data cannot be linked to individual level data on socio-economic status in England. Therefore, we aggregate to the level of 32,482
English small areas with average population of 1,500 and use available indices of small area socioeconomic deprivation.
The concept of equity we examine is small area socio-economic equality in health care utilisation for equal need. We estimate fixed effect linear panel data models of small area hospital utilisation as a function of population need, deprivation and market structure. The competition effects on equity are identified by examining how the interaction between market structure and deprivation changes over time. Changes in equity over time can be more robustly identified than levels of equity at a given point in time. Levels of equity are hard to quantify in cross sectional analysis because one has to assume that observed utilisation inequalities relative to need are not biased by unobserved heterogeneity in population need.
By contrast, our identification of equity effects rests on the more reasonable assumption that unobserved heterogeneity in population need between more and less deprived areas remains stable from one year to the next. Cookson et al (in press) measure inequality in utilisation of hospital care at the small area level in England between 2001 and 2008 and provide a discussion on the differences between level and trend inequality analysis.
To facilitate the discussion throughout the paper, we interpret a relative increase in hospital utilisation in deprived areas as a beneficial improvement in socio-economic equity, and a relative decrease as a harmful deterioration in socio-economic equity.
Background

The Blair/Brown pro-competition reforms of the English NHS
The Blair/Brown reforms involved both supply side and demand side mechanisms for introducing hospital competition. On the supply side, independent sector (IS) providers were encouraged to enter the market for publicly funded NHS patients, initially through the "Independent Sector Treatment Centre" programmeme of nationally agreed contracts with generous terms (Mason et al., 2010 provider, leading up to "free choice" of any public or independent hospital in the NHS national directory from April 2008 (Dixon et al., 2010) . This was coupled with a national system of fixed price case based hospital payment based on a local variant of DRGs ("Healthcare Resource Groups"), which was gradually phased in nationally from 2003/4 for a small basket of elective inpatient services and progressively expanded to include all elective services in 2005/6. The financial impact of this policy on hospital revenue was also gradual with a four year transition path which came to an end in 2008/9. Prior to these reforms, NHS patients largely had to accept whatever referral their GP made for them and hospitals were largely paid on the basis of block contracts negotiated with local public agencies ("Primary Care Trusts") responsible for purchasing health care on behalf of the local population.
All of these reforms were introduced alongside substantial growth in NHS expenditure. From 1999 to 2010, real annual NHS spending growth averaged 6.56% compared with 3.48% from 1950/01 to 1999 (Appleby et al., 2009 (Department of Health, 2000 , 2004 . There is evidence that these reforms increased hospital competition and that this competition improved hospital quality (Cooper et al., 2010; Gaynor et al., 2010) . However, there is no evidence about the effects of hospital competition during the Blair/Brown reform period on socio-economic equity.
Economic theory on the relationship between competition and equity
This paper tests the hypothesis that fixed price competition in the context of universal health insurance tends to undermine socioeconomic equity in health care. This is an empirically driven hypothesis motivated by policy debates between critics and proponents of procompetition reform in health care, rather than a theoretically driven hypothesis motivated by economic theory. Nevertheless, it is worth considering whether economic theory can elucidate this hypothesis.
Economic theory offers competing predictions about the relationship between competition and socioeconomic status. For example, increased competition could in theory improve equity by increasing activity volumes, if the marginal patient brought into the market is a low-income one. In what follows, however, we describe three possible theoretical explanations for why competition in the context of the English NHS might undermine equity in health care.
Reduced rent for pursuing equity objectives Hospital objective functions might be partially benevolent, incorporating concern for equity in health care. As a result, hospitals may seek to make implicit transfers to relatively sick or poor or otherwise disadvantaged individuals. In theory, hospital competition might therefore undermine equity by reducing the rents available to hospitals for making implicit transfers of this kind. In a US context, the implicit transfers might take the form of price discrimination against well-insured individuals and in favour of under-insured individuals. In an English NHS context of universal insurance coverage and fixed prices, by contrast, the implicit transfers might take the form of treating unprofitable high-cost patients -i.e. refraining from engaging in profit-maximising "creaming" and "dumping" behaviour (Ellis 1998). If poor patients are more expensive to treat within the HRG service provided -for example, because they are harder to discharge -and hence relatively unprofitable to treat under a fixed price system, then competition may reduce the rent available to managers to make implicit transfers to such patients by treating them. This could lead to creaming and dumping behaviour which could take the form of tighter hospital admission thresholds for such patients for elective care, resulting in reduced treatment volumes and not merely diversion of patients from one hospital to another. However, evidence that poor patients cost substantially more is mixed (Epstein et al., 1990; Cookson et al., 2011) .
Crowding out of pro-social motivation
Critics of pro-competition reform often warn that competition might erode the pro-social motivation of hospital managers and clinicians, with harmful consequences for equity (Tudor Hart 2006) . According to the behavioural economic theory of "motivation crowding out" (Frey and Oberholzer-Gee, 1997) , the introduction of incentive mechanisms with "extrinsic"
rewards and punishments -such as competition -may cause pro-social motivation to be crowded out by self-interested motivation. To put it in Le Grand's colourful terminology, competition may encourage hospital managers and clinicians to behave more like selfinterested "knaves" than pro-social "knights" (Le Grand, 2003) . As before, however, this explanation only makese sense in the context of universal health insurance and fixed prices if poor patients cost more and are less profitable to treat.
Choice and waiting times
Waiting times and waiting lists are used as a rationing mechanism to regulate access to hospital care in England, and before the introduction of the reform a large number of patients were waiting longer than 12 months for treatment. Thus, the early political debate on competition focused on the potential role of patient choice in reducing waiting times.
Opponents of the reform argued that patient choice of provider would advantage skilled patients from higher socioeconomic groups, since they face lower costs in accessing information and have greater willingness to travel away from their local hospital provider in order to get their treatment quicker. This in turn would result in a larger volume of services being allocated to such patients every year as compared with socioeconomically disadvantaged patients who face higher costs in exercising choice and hence are more likely to stay on the waiting list of their local hospital provider. In contrast, advocates of reform claim that this sort of two tier system was already in place before the introduction of competition, with socioeconomically advantaged individuals travelling longer distances (Propper et al 2007) in order to obtain their treatment in hospitals with shorter waiting times (Laudicella et al. 2012 , Cooper et al 2009 . The introduction of choice and competition would then benefit socioeconomically disadvantaged patients by making it easier for them to choose hospitals with shorter waiting times (Dixon and Le Grand, 2006) . Year by year utilisation rates per 100,000 population for all elective adult inpatient hospital utilisation are reported in Table 2 , based on mid-year population estimates from the Office for National Statistics (ONS).
Data
Indices of hospital market structure
We measure market structure using a Herfindahl-Hirschman Index (HHI) of hospital market concentration. The index is defined as the sum of the squared market shares of all hospitals in the market, and normally ranges from 0 (max market dispersion) to 10,000 (max market concentration).
In our analysis, a "hospital" is defined as either an NHS Trust (a group of local public hospital sites funded and managed under the same organisational umbrella) or an independent sector provider site. Our data on market shares include patient flows to both NHS Trusts and IS sites; though in sensitivity analysis we also construct indices based on NHS Trusts only.
We calculate two versions of the HHI using two different approaches. The first is based on observed patient flows from their GP practice 2 to the hospital, and is calculated separately for each year from 2003 to 2008 as described in Appendix 1. The "observed HHI" assumes the GP practice is the relevant market unit since in the English hospital market patients access elective care through a referral from their GP. Also, a number of surveys conducted by the Department of Health show that the patient's GP is the most important source of information when patients choose the hospital for their treatment 3 . However, GPs received specific guidelines to offer at least four alternative hospitals to their patients and they have no incentives for establishing exclusive relations with one particular hospital. Also, patients can "choose and book" completely autonomously using an internet booking facility that provides information on hospital services, distance and waiting times. In sensitivity analysis, we therefore also calculate an alternative version of this index using the patient small area of residence (i.e. the LSOA) as the initial market unit in place of the GP practices. We find a 90% correlation between these two versions of the observed concentration index. This is not surprising given that patients typically choose a GP practice close to their home in order to minimize travel costs.
The second version of the HHI is based on predicted probabilities of patients being admitted to any hospital. Estimated probabilities are based on the interaction between exogenous patient and hospital characteristics that are likely to influence the patient's choice of hospital.
Therefore, the "predicted HHI" is purged of potential bias from unobservable patient and hospital characteristics, such as hospital quality or patient health status. This index is based on the works of Kessler and McClellan (2000) and Gowrisankaran and Town (2003) and is described in Appendix 2. We construct the predicted HHI using observations in 2003 and 2008 only, since its calculation requires a considerable amount of data and computer resources.
Finally, we compute a time varying index of independent sector penetration, in order to test the hypothesis that apparent effects of competition are an artefact of increases in local hospital capacity rather than a real increase in competition. This index simply counts the 3 Reports on the National Patient Choice Survey, July, December, January 2008.
number of independent sector providers within a 60km fixed radius distance from the LSOA demographic centroid. We also conduct sensitivity analysis using a 15km, 30km and 45km radius and including IS providers with at least 1,000 NHS patient admissions only, though we are not able to produce an indicator of IS penetration based on the number of beds due to lack of data on IS providers. We find that the largest impact on elective admissions is obtained using a 60Km radius and including all IS providers with at least 100 NHS patient admissions.
Area deprivation
Small area socio-economic status is measured using the income deprivation domain of the We use this index because it is easy to interpret on a cardinal scale suitable for regression analysis and does not include any health related variables that might introduce circularity into the modelling. For most of the analysis, we treat this index as a cardinal variable. This allows us to take account of the full socio-economic distribution and avoids the potential selection biases associated with focusing on ratios or gaps between arbitrarily defined extreme groups.
In one illustrative graph, however, we use this index to categorise small areas as "deprived"
or "non-deprived" in terms of the absolute proportion of individuals living in low income households: (1) 0-20% ("low deprivation") and (2) 20% or more ("high deprivation"). This generates two unequally sized groups comprising 72.2% and 27.8% of small areas respectively. We also conduct a sensitivity analysis using the Economic Deprivation Index (Noble et al., 2009 ). This index measures income deprivation among individuals aged under 60 and is time-varying for the first three years of our period from 2003 to 2005 but frozen thereafter for the next three years.
Need and GP supply variables
We control for a range of time varying small area need variables including population size, age-sex structure, and disease prevalence. We use ONS mid-year population estimates in 5 We attribute this to the small area level using the Attribution Dataset of patient registration addresses within GP practices. The attribution process assumes that prevalence for a particular small area is a weighted sum of the prevalence in each GP practice serving that small area, with weights proportional to the number of small area residents registered with each GP practice. Both the QOF data and practice to small area attribution data were obtained from the NHS Information Centre. Eight of the twelve variables we use are available from 2004/5, though four of them (atrial fibrillation, chronic kidney disease, heart failure and obesity) are only available from 2006/7 following a revision to the QOF scheme.
Most of the disease prevalence variables are based on the full population of patients registered with the GP practice. However, diabetes prevalence is based on patients aged 17 and over; epilepsy and chronic kidney disease is based on patients aged 18 and over; and obesity prevalence is based on patients aged 16 and over.
We also control for time varying GP supply, by computing GPs per 10,000 population. This variable is based on GP practice level administrative data on whole time equivalent GPs per registered patient, from the General Medical Services database. This GP practice level variable is then attributed to LSOA level using the same procedure described above, as a weighted average based on the share of GP practice registered patients resident in the LSOA.
Methods
We model small area utilisation as a function of local market structure, a time trend, and population demographic and need variables. We use small area level fixed effects to allow for unobserved heterogeneity between small areas in local supply and demand factors that did not change between 2003 and 2008. The effect of each explanatory variable is therefore identified using within-area variation over time rather than between-area variation in global mean levels of the variables across all periods. We use a fixed effects specification in order to control for unobserved heterogeneity between small areas in time invariant characteristics likely to be correlated with local market structure, such as historical supply and demand factors that generate between-area variations in global mean utilisation, market structure and need.
Our small area level regression equation can be written:
Where:
it y is the utilisation count in small area i in year t.
dispersion it is an index of market dispersion obtained by multiplying the HHI by -1/100. is a vector of time varying control variables, including need variables (small area population size and demographic characteristics and prevalence of diseases) and supply variables (number of independent sector hospitals within 60km and whole time equivalent GP numbers).
is the small area fixed effect.
In all regression models, we use an index of market dispersion obtained simply by multiplying the HHI concentration index by a constant term (-1/100) so that the index measures increasing market dispersion rather than concentration and ranges from -100 (minimum market dispersion, i.e. monopoly) to 0 (maximum market dispersion). This facilitates the interpretation of the model coefficients and in terms of marginal effects of increasing market dispersion and increasing competition rather than increasing concentration and decreasing competition. Also, we treat income deprivation as a continuous variable on a scale of 0 to 100.
We estimate the effect of competition on equity using two model specifications based on equation ( The effect of competition on socio-economic equity is identified using a three-way interaction term between the indicator of local market dispersion, the indicator of small area deprivation, and a year dummy variable capturing the introduction of the competition reform.
The estimated coefficient ("theta") on this crucial three-way interaction term can be interpreted as the effect of competition on utilisation by increasing level of deprivation. Or, equivalently, it can be interpreted as the effect of deprivation on utilisation by increasing levels of competition.
The baseline effect of deprivation on utilisation is not identified by our fixed effect model since our indicator of deprivation is not time varying. However, we can identify change over time in the effect of deprivation, based on within-area change over time in utilisation. The Our identification of the effect of competition is obtained through the within small area variation in the level of market dispersion that is generated by the introduction of the reform.
Before the reform, English health markets are hierarchically controlled systems where patients cannot choose providers and the latter are not in competition to attract patients.
Variations in market dispersion are very small, and are associated with variations in demand and supply factors rather than variations in hospital competition. Pro-competition reform then changes the market structure, inducing an exogenous change to the level of market dispersion that affects some areas more than others. Therefore, the reform provides a natural experiment allowing us to identify the effect of competition.
Identification of the effect of competition on elective admissions can be achieved straightforwardly, in the absence of time variant unobservable confounders correlated with market dispersion, under the standard "parallel trends" assumption of the DID estimator.
However, the effect of competition on elective admission is not the focus of this paper. The identification of the effect of competition on equity, i.e. the parameter , is obtained assuming absence of unobservable time variant confounders correlated both with market structure and deprivation. This assumption is slightly different than the standard identification hypothesis of DID estimators. Time variant policy confounders are allowed to be correlated with market dispersion or deprivation as long as they are not correlated with both. For instance, imagine the implementation of the competition reform were accompanied by extra health care resources in areas with highly dispersed markets. This would lead to bias in the estimated effect of competition on utilisation (i.e. coefficients and ). However, the effect of competition on equity (i.e. coefficient ) can still be identified provided that the extra funding is randomly allocated between deprived and non-deprived areas. Identification of the effect of competition on equity is achieved by subtracting the effect of market dispersion from the effect of deprivation pre and post the introduction of the reform.
Therefore, the coefficient is still identified even when the coefficients and are not, provided that the bias affects deprived and non-deprived areas equally. 6 Therefore, the identification assumption of the three-way interaction term is similar to the DDD estimator.
One of the confounders potentially capable of influencing the relationship between deprivation, competition and utilisation could be the entry of independent sector providers into NHS market during this period. Independent sector providers were authorised and incentivised to enter hospital markets with lack of supply, which were often characterised by low market dispersion and located in income deprived areas. We control for this potential confounding effect by including in the regression analysis a time varying indicator of independent sector penetration in the local hospital markets. The indicator counts the number of independent sector providers within 60Km fix radius distance from the small area. 
Equation 2 assumes that pre-reform market characteristics are exogenous and allows for the identification of the main parameter of interest θ, i.e. the effect of competition on equity.
However, equation 2 cannot identify the association between market dispersion and utilisation (δ) and market dispersion and equity (ω) at the baseline year 2003. Figure 2 shows crude annual utilisation trends in all elective inpatient admissions broken down by two dispersion groups ("low dispersion" and "high dispersion") and two deprivation groups ("low deprivation" and "high deprivation"). In 2003, "low dispersion" areas have substantially higher hospital utilisation than "high dispersion" areas. Furthermore, within both dispersion groups, "high deprivation" areas have higher utilisation than "low deprivation" areas in 2003. Utilisation then grows over time in all four groups, though more rapidly in "high dispersion" than "low dispersion" areas.
Results
Change in hospital market structure between 2003 and 2008
Equity effects on all elective inpatient hospital utilisation
Within the "low dispersion" group, utilisation grows faster in the "low deprivation" areas.
By contrast, within the "high dispersion" group, utilisation grows slightly faster in the "high deprivation" areas. Growth of utilisation in deprived areas was thus faster within the "high dispersion" group of areas than the "low dispersion" group. By 2008, the "dispersed, deprived" group had caught up with the "non-dispersed, deprived group", whereas the "dispersed, non-deprived" group still lagged behind the "non-dispersed, non-deprived" group.
Insofar as the "high dispersion" group is likely to face a larger increase in competitive pressure during the period, this is suggestive evidence that competition may have helped to facilitate growth in elective hospital admissions in deprived areas and thus to improve socioeconomic equity.
We now turn to the regression results, to examine competition effects on equity using more rigorous statistical methods that control for confounding factors and are less sensitive to the arbitrary definition of dispersion groups and deprivation groups. Our regression results are perhaps easiest to understand in graphical form, since the interaction terms can be hard to interpret. Figure 3 shows how the marginal effect of local market dispersion on utilisation varies by deprivation and over time. The graph is obtained by plotting the coefficients estimated using model 1 (table 3) . It shows the change in total elective admissions associated with a one unit change in market dispersion by deprivation and year. In 2003 a one unit increase in the dispersion index (i.e. a drop in the HHI of 100 points) leaves utilisation unchanged in non-deprived areas (i.e. areas with IMD index = 0), decreases utilisation by 1 admission in areas with 10-20% of resident relying on income benefits (i.e. the average deprivation areas), and by 4 admissions in areas with over 50% of residents relying on income benefits (i.e. the most deprived 5% of areas). After the introduction of the competition reform this negative association reduces in areas with average deprivation and particularly in the most deprived areas, while it remains substantially unchanged in non deprived areas. Therefore, competition has slightly increased utilisation in deprived areas. We now turn to the full regression results, for completeness. equity is robust to the use of either the observed or the predicted competition index. Table 4 reports the results of our sensitivity analyses using a time varying index of income deprivation (i.e. the income domain of EDI index) and the predicted competition index. We obtain precisely the same pattern of results produced by model 2. Table 5 shows results of our sensitivity analysis using a competition index fixed at pre-reform level of market dispersion as described in Equation 2. This alternative model specification relaxes the functional form assumption of Model 1 and produces very similar results. We can offer two possible speculations as to why competition appears to have very slightly increased elective inpatient admissions in deprived areas. One is that patient choice was particularly beneficial to deprived patients living in "high choice" areas with dispersed hospital markets, in helping them choose hospitals with lower waiting times. In turn, this may have increased utilisation in those deprived areas by reducing local waiting list backlogs and allowing local clinicians to lower referral and treatment thresholds. Another possible speculation is that competitive pressure may have generated market incentives for hospitals to seek out profitable new business among patients with previously unmet needs, who may disproportionately reside in deprived areas. However, the effect is so small as to be negligible from a national policy perspective, and so we cannot conclude that competition improved socio-economic equity to any meaningful extent. association cannot be attributed to competition in 2003 but must instead be the result of unobserved historical factors. One possible speculation is that the association may be due to population growth in some metropolitan areas during the 1980s and 1990s outstripping growth in hospital capacity in those areas. Those areas may therefore tend to have both low utilisation rates per head of population and relatively dispersed hospital markets compared with rural areas with low population density and few local hospitals. Our fixed effect specification purges the effect of this historical between-area association from our estimates.
The predicted HHI provides substantially smaller estimates of the effect of competition on elective admissions than the observed HHI. The former is calculated excluding potentially endogenous factors, such as hospital quality and waiting times. Hospitals that increase capacity are likely to expand their market share by lowering waiting times and hence becoming more appealing to patients. This might explain the difference in the estimated effect of competition when using the observed HHI as compared with the estimated HHI.
However, both indices provide similar predictions of the effect of competition by deprivation and year. This suggests that the bias might equally affect deprived and non-deprived areas, and hence may cancel out in the DID setting.
Finally, we find that allowing for IS penetration generally reduces the effect of market dispersion as expected, but does not affect the key coefficient on the three way interaction terms between market dispersion*deprivation*time under all model specifications.
Methodological strengths and limitations
One strength of our study is the use of panel data methods to identify effects of competition.
We exploit both change in local market dispersion within small areas and change in policy regime to identify effects of competition. This is more powerful than relying on cross sectional variation in market dispersion between small areas, which may be correlated with unobservable historical and geographical determinants of hospital utilisation that have nothing to do with competition. Also, our study uses a measure of competition based on predicted HHI as well as observed HHI. This allows for potentially endogenous factors influencing the patient choice of hospitals such us hospital quality and patient health status.
A third strength is that our study covers all adult patients in the English NHS. This is an important advantage of administrative data over survey data. Our study is representative of all sections of the community including the most socio-economically deprived individuals who are sometimes hard to include in sample surveys. Moreover, we have a sufficient number of observations to detect statistically significant changes in equity trends associated with changes in competition.
This study also has several limitations. First, we only observe socio-economic status at the level of small areas -with mean population 1,500 -and not at the level of individuals. This means that we can only draw conclusions about people living in low income areas, since not all individuals living in low income areas have low socio-economic status. Nevertheless, living in a low income area is a reasonable proxy for low socio-economic status, since housing in England is highly segregated by socio-economic status and LSOA boundaries were designed by ONS to delineate relatively homogenous small areas in terms of socioeconomic status and other social factors. Second, we focus on hospital admissions and do not directly examine equity in primary care. However, all of our hospital utilisation indicators potentially capture inequities arising at the primary care stage in the patient pathway. Third, like all administrative datasets, HES contains coding and measurement errors. One possible source of bias is missing data for Independent Sector (IS) providers. If IS patients are less likely to be drawn from deprived communities, the missing data could in theory obscure disproportionate rises in IS activity in affluent areas. However, mean area deprivation is not much lower among IS patients than among patients treated by NHS Trusts: only 1.56
percentage points lower in a recent study of 2007/8 data covering 78% of procedures coded in IS activity (Mason et al. 2010 ). Furthermore, IS activity makes up a relatively small proportion of NHS activity in the early years of the ISTC programme when coding was particularly poor -less than 1% until 2006/7 -and activity coding has improved since then (NHS Information Centre 2009). Missing data on IS activity is thus unlikely to be sufficiently large proportion of total activity to bias our results. A final limitation is that we only examine inequality in the volume of hospital care, as opposed to the quality and outcomes of hospital care. We therefore cannot test hypotheses about effects of competition on quality of care or theoretical stories about deprived patients being less able than affluent patients to avoid low quality hospitals due to poor information and reluctance to travel long distances.
Comparison with other studies
Our main finding that hospital competition had no substantial effect on socio-economic equity during the Blair/Brown reforms is consistent with previous findings about the effects of hospital competition during the Thatcher/Major "internal market" reforms of the NHS in the 1990s. Using different methodologies, two small area study of NHS hospital episode statistics from 1991 to 2001 found that the NHS "internal market" reforms had no impact on socio-economic inequalities in hip replacement ) and hip replacement and revascularisation (Cookson et al., 2010) . Like the Blair/Brown reforms, however, the "internal market" reforms of the 1990s involved a relatively small dose of hospital competition.
Our findings are also consistent with studies of overall trends in small area socio-economic equity during the 2000s, which have generally shown no change during the period -including small area socio-economic equity in waiting times for hip replacement, knee replacement and cataract surgery from 1999 to 2007 (Cooper et al., 2009) , rates of preferred surgery for colorectal, breast and lung cancer between 1999 and 2006 (Raine et al., 2010) and rates of all elective inpatient admissions, all outpatient visits, hip replacement, cataract surgery, gastroscopy and coronary revascularisation (Cookson et al., in press ).
Taken together with the results of other studies, our results suggest that socio-economic patterns of health care utilisation are deeply ingrained, and that small doses of "quasi market"
competition have little or no effect on socio-economic equity in health care in the context of universal and comprehensive health systems. Predicted HHI (*) (**) 4,096 n/a n/a n/a n/a 4,013 n/a n/a year2005 -1.300 (3.129) n/a n/a year2004 -1.867 (2.272) n/a n/a
Model 1 Model 2 (Observed competition index) (Predicted competition index)
Notes to table 3:
1. Results from linear panel data models with fixed effects 2. Dependent variables: all elective hospital admissions 3. Unit of analysis: small areas (LSOAs) 4. Both models include controls for: GPs per 10,000 population, population size, age-sex fractions and prevalence of diseases described in Table 1 (coefficients not shown). 5. Baseline: zero deprivation and zero competition areas in 2003. 6. Dispersion is measured by using the HHI indices of market concentration described in Appendix 1 and 2. Both indices are re-scaled from -100 (min market dispersion) to 0 (max market dispersion) to facilitate the interpretation of the regression results. 7. Deprivation is measured by using the income domain of the Indices of Multiple Deprivation 2007.
Scale from 0 to 100, with 100 representing 100% of individuals from households on low income benefits. Deprivation is fixed over time, so its effect cannot be separately identified from the fixed effects in both models. 8. Robust standard errors clustered by small areas in parentheses. 9. ** p<0.01, * p<0.05 index is re-scaled from -100 (min market dispersion) to 0 (max market dispersion) to facilitate the interpretation of the regression results. 7. Deprivation is measured by using the income domain of the Indices of Multiple Deprivation 2007.
Scale from 0 to 100, with 100 representing 100% of individuals from households on low income benefits. Deprivation is fixed over time, so its effect cannot be separately identified from the fixed effects in both models. 8. Robust standard errors clustered by small areas in parentheses. 9. ** p<0.01, * p<0.05 Year -1.00-0.00 -2.00--1.00 -3.00--2.00 -4.00--3.00 -5.00--4.00
Marginal effect
In order to test whether hospital competition is influenced by GP practice styles, we construct an alternative version of the HHI concentration index described above. This index uses patient small area of residence as the relevant market unit and is also based on a three step procedure. In the first step, we calculate the HHI at the level of patient area of residence based on observed shares of patient residents admitted to any hospitals. The second and the third steps are the same as in the previous version of the index. We find 90% correlation between the two versions of the index and very similar results in the empirical analysis.
Appendix 2
The identification of the effect of competition on equity in utilisation is potentially exposed to endogeneity bias when using an index of competition based on observed patient flows to hospitals. For example, a hospital investing in extra capacity might attract larger patient flows by lowering its waiting time, thus influencing both market structure and absolute utilisation volume. Moreover, the relationship between patient volumes and patient shares might vary by the socioeconomic characteristics of patients. Patients from lower socioeconomic back grounds might not be willing to travel long distances and choose a different provider from their local hospital (Propper et al., 2006) . Finally, patient flows might be affected by unobservable characteristics of patient health status, which are potentially correlated with their socioeconomic background.
To overcome potential problems of endogeneity, we follow the approach described in Kessler and McClelland (2000) and Gowrisankaran and Town (2003) and measure competition using patient travel distances that are exogenous to unobserved characteristics of patients and hospitals. The predicted competition index at the small area level is obtained following a three steps procedure.
In the first step, we specify a model of hospital choice at the patient level as a function of exogenous determinants of the patient admission using the following specification of the patient indirect utility function (Kessler and McClellan, 2000) :
The utility of patient i from choosing the hospital j depends on: the relative distance of hospitals of a similar h type to hospital j -captured by the vector in the first term of We allow for three different types of hospitals in our model -large public hospitals, teaching hospitals, independent sector hospitals. Also, we allow for individual characteristics such as patient severity (i.e. patient admitted with just one diagnosis, 2-3 co-diagnoses and more than three), patient age (i.e. patients aged from 18-50 and more than 50), patient socioeconomic status (i.e. patients from the most income deprived 20% of small areas). We restrict the choice set to all hospitals within 100km fix radius conditional of having at least one hospital of each type in the choice set.
The model described in equation 2 is used to predict the probability of each patient admission:
Where are the hospitals in the choice set of individual i. Equation 3 is solved by maximising the following log-likelihood function:
We estimate equation 4 using a conditional logit separately for 2003 and 2008.
In the second step, we can calculate the hospital level HHI following Gowrisankaran and
Town (2003):
With:
∑ ̂ and ̂ ∑ ̂ Following Kessler and Mclellan (2000) and Gowrisankaran and Town (2003) , we exclude patient level and hospital level characteristics from the main effects entering equation 2 and obtain an index of competition based on exogenous determinants of patient flows rather than potentially endogenous factors.
In the third step, we attribute the hospital level competition index obtained from equation 5 to small areas using a weighted average of public hospital HHI. We weight the hospitals' HHI by the inverse of their distance to the demographic centroid of the LSOA:
falling within a radius of 60km from the small area demographic centroid and attribute an equal distance to hospitals located within a radius of 5Km. Fixing the LSOA market radius at 60Km prevents to artificially inflate the competition of those LSOAs having few hospitals in their closest neighbourhood. The contribution of distant hospitals is indirectly included in the LSOA market through their competition interactions with local hospitals as described in equation 5. In sensitivity analysis, we use alternative fix radius indices (30Km and 45Km) and find the completion indices are highly correlated and produce very similar results.
